Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.

× No keyword cloud information.

23 in total

Review 1. Cancer Biomarkers for Integrative Oncology.

Authors: Aniruddha Ganguly; David Frank; Nagi Kumar; Yung-Chi Cheng; Edward Chu
Journal: Curr Oncol Rep Date: 2019-03-05 Impact factor: 5.075

2. A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906.

Authors: Robert Tilton; Anthony A Paiva; Jing-Qu Guan; Rajendra Marathe; Zaoli Jiang; Winfried van Eyndhoven; Jeffrey Bjoraker; Zachary Prusoff; Hailong Wang; Shwu-Huey Liu; Yung-Chi Cheng
Journal: Chin Med Date: 2010-08-20 Impact factor: 5.455

3. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.

Authors: Sara Rockwell; Tina A Grove; Yanfeng Liu; Yung-Chi Cheng; Susan A Higgins; Carmen J Booth
Journal: Int J Radiat Biol Date: 2012-09-03 Impact factor: 2.694

4. Botanical Formula LCS101: A Multi-Targeted Approach to Cancer Care.

Authors: Yair Maimon; Noah Samuels; Zoya Cohen; Raanan Berger; David S Rosenthal
Journal: Integr Cancer Ther Date: 2018-10-10 Impact factor: 3.279

5. Chinese medicine and biomodulation in cancer patients--Part one.

Authors: S M Sagar; R K Wong
Journal: Curr Oncol Date: 2008-01 Impact factor: 3.677

Review 6. Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges.

Authors: Foon Yin Fung; Yeh Ching Linn
Journal: Evid Based Complement Alternat Med Date: 2015-04-08 Impact factor: 2.629

7. Therapeutic applications of herbal medicines for cancer patients.

Authors: Shu-Yi Yin; Wen-Chi Wei; Feng-Yin Jian; Ning-Sun Yang
Journal: Evid Based Complement Alternat Med Date: 2013-07-11 Impact factor: 2.629

8. YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment.

Authors: Xiaochen Yang; Wing Lam; Zaoli Jiang; Fulan Guan; Xue Han; Rong Hu; Wei Cai; William Cheng; Shwu-Huey Liu; Peikwen Cheng; Yuping Cai; Nicholas J W Rattray; Caroline H Johnson; Lieping Chen; Yung-Chi Cheng
Journal: Sci Rep Date: 2021-06-29 Impact factor: 4.379

9. Effect of the Botanical Compound LCS101 on Chemotherapy-Induced Symptoms in Patients with Breast Cancer: A Case Series Report.

Authors: Noah Samuels; Yair Maimon; Rachel Y Zisk-Rony
Journal: Integr Med Insights Date: 2013-01-22

10. PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.

Authors: Wing Lam; Zaoli Jiang; Fulan Guan; Xiu Huang; Rong Hu; Jing Wang; Scott Bussom; Shwu-Huey Liu; Hongyu Zhao; Yun Yen; Yung-Chi Cheng
Journal: Sci Rep Date: 2015-03-30 Impact factor: 4.996